|
|
|
|
|
|
|
|
|
|
|
21.10.25 - 12:30
|
Elevance Health Inc. Q3 Income Advances (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Elevance Health Inc. (ELV) released a profit for its third quarter that Increases, from last yearThe company's earnings totaled $1.189 billion, or $5.32 per share. This comp......
|
|
|
|
|
|
|
21.10.25 - 12:06
|
Elevance Health Reports Third Quarter 2025 Results (Business Wire)
|
|
|
Executing with discipline to improve affordability and elevate the member experience
3Q 2025 operating revenue of $50.1 billion, up 12.0% from 3Q 2024
3Q 2025 diluted EPS1 of $5.32; adjusted diluted EPS2 of $6.03
Reaffirm FY 2025 benefit expense ratio and adjusted diluted EPS guidance of approximately 90.0% and approximately $30.00, respectively
Returned $3.3 billion of capital to shareholders year-to-date
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results.
"Our third quarter results were in line with expectations and reflect disciplined execution across Elevance Health. In a dynamic healthcare environment, we're focused on advancing affordability and elevating the member experience through our growing value-based care partnerships and AI-enabled digital solutions that simplify access and improve outcomes. As we plan for 2026, we remain disciplined in managing what we can control – positioning our businesses for long-term, sustainable growth and va...
|
|
|
|
|
|
|
|
|
|
|
02.10.25 - 14:03
|
Autonomize AI Welcomes Michele Paige and Tamara Elias, MD to Growth Advisory Board (Business Wire)
|
|
|
Seasoned healthcare and technology leaders bring critical expertise to guide Autonomize AI's next stage of growthAUSTIN, Texas--(BUSINESS WIRE)--Autonomize AI, the pioneer in Agentic AI orchestration for healthcare and life sciences, today announced the appointment of Michele Paige and Tamara Elias, MD to its Growth Advisory Board. They join a distinguished group of leaders—including Joan Harvey, Pritesh Gandhi, MD, MPH, Anthony Nguyen, MD, MBA, and Sarah Bezerredi—who are shaping Autonomize's strategy as the company scales its impact across health plans, providers, and pharmacy benefit management organizations.
Michele Paige brings deep expertise in PBM and pharmacy operations, having led product and digital strategy at Elevance Health's CarelonRx. Her leadership in specialty pharmacy and affordability initiatives will be critical as Autonomize AI accelerates the expansion of its enterprise AI platform and marketplace of pre-built, pre-trained AI Agents into pharmacy-linked workflows.
Tamara Elias...
|
|
|
29.09.25 - 22:36
|
Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2025 Results on October 21 (Business Wire)
|
|
|
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
888-947-9963 - Access Code - 3972058 (Domestic)
312-470-0178 - Access Code - 3972058 (International)
800-391-9853 - No Access Code (Domestic Replay)
203-369-3269 - No Access Code (International Replay)
The replay will be available from 11:30 a.m. EDT on October 21, 2025, until the end of the day on November 21, 2025. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.
About Elevance Health
Elevance Health is a lifetime, trusted health partner whose purpose is to i...
|
|
|
|
|
|
|
|
|
10.09.25 - 23:27
|
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Notes (Business Wire)
|
|
|
OLDWICK, N.J.--(BUSINESS WIRE)--#insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health Inc.'s (Elevance Health) (headquartered in Indianapolis, IN) newly issued senior unsecured notes of $750 million, 4.0% senior unsecured notes, due 2028; $750 million, 4.6% senior unsecured notes, due 2032; $1 billion, 5.0% senior unsecured notes, due 2036; and $500 million, 5.7% senior unsecured notes, due 2055. The outlook assigned to this Credit Rating is stable.
The proceeds from the debt issuances are expected to be used for general corporate purposes, which may include investments and pre-fund debt maturities due in October 2025 and the first quarter of 2026. AM Best anticipates the issuances to temporarily increase the company's financial leverage ratio to just over 43%. However, financial leverage should moderate after the repayment of the few upcoming maturities, but will remain slightly over Elevance Health's long-term target of 40% going into fourth-quarter ...
|
|
|
08.09.25 - 23:54
|
XETR: DIVIDEND/INTEREST INFORMATION - 10.09.2025 - US0367521038 (XETRA)
|
|
|
Das Instrument A58 US0367521038 ELEVANCE HEALTH DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 09.09.2025 und ex Dividende/Zinsen am 10.09.2025
The instrument A58 US0367521038 ELEVANCE HEALTH DL-,01 EQUITY has its pre-dividend/interest day on 09.09.2025 and its ex-dividend/interest day on 10.09.2025...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
